Bicycle Therapeutics Plc (BCYC)
5.42
+0.06
(+1.12%)
USD |
NASDAQ |
Feb 13, 11:34
Bicycle Therapeutics Cash from Investing (Quarterly) : -0.6709M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0656M |
| Mereo BioPharma Group Plc | 0.3027M |
| Autolus Therapeutics Plc | 35.49M |
| DBV Technologies SA | -0.2404M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -70.63M |
| Cash from Financing (Quarterly) | -0.0297M |
| Free Cash Flow | -242.07M |
| Free Cash Flow Per Share (Quarterly) | -1.029 |
| Free Cash Flow to Equity (Quarterly) | -69.80M |
| Free Cash Flow to Firm (Quarterly) | -71.27M |
| Free Cash Flow Yield | -64.54% |